Unlock instant, AI-driven research and patent intelligence for your innovation.

Triazole agonists of APJ receptors

A technology of tautomers and alkyl groups, applied in the field of triazole agonists of APJ receptors

Active Publication Date: 2020-09-22
AMGEN INC
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] Another study reported synthetic analogs of apelin-13 with amino acid substitutions at the C-terminus of the molecule with atypical amino acids, but no peg-2 at the N- or C-terminus or another site-specific position. Alcoholization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Triazole agonists of APJ receptors
  • Triazole agonists of APJ receptors
  • Triazole agonists of APJ receptors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0104] For convenience and for ease and clarity of reference when referring back to the various embodiments, the following embodiments are presented in numbered form.

[0105] 1. In a first embodiment, the present invention provides a compound of formula I or formula II:

[0106]

[0107] or a pharmaceutically acceptable salt thereof, a tautomer thereof, a pharmaceutically acceptable salt of said tautomer, a stereoisomer of any of the foregoing, or a mixture thereof,

[0108] in:

[0109] R 1 is unsubstituted pyridyl, pyridone or pyridine N-oxide, or is surrounded by 1, 2, 3 or 4 R 1a Substituent substituted pyridyl, pyridone or pyridine N-oxide;

[0110] R 1a independently in each case selected from -F, -Cl, -Br, -I, -CN, -C 1 -C 6 Alkyl, -C 1 -C 6 Haloalkyl, -C 1 -C 6 Perhaloalkyl, -OH, -O-(C 1 -C 6 Alkyl), -O-(C 1 -C 6 haloalkyl), -O-(C 1 -C 6 perhaloalkyl), -C 2 -C 6 Alkenyl, -O-(C 1 -C 6 Alkyl)-OH, -O-(C 1 -C 6 Alkyl)-O-(C 1 -C 6 Alkyl), -O-(C ...

Embodiment 1

[1266] Example 1: Preparation of 2-isothiocyano-1,3-dimethoxybenzene.

[1267]

[1268] 2-Isothiocyano-1,3-dimethoxybenzene, Example 1.0. To a solution of 2,6-dimethoxyaniline (500 g, 3.25 mol, 1 equiv) in DCM (5.0 L) was added 2,6-lutidine (1.5 L, 13.0 mol, 4 equiv). The reaction mixture was cooled to 0°C (internal temperature) and CSCl was added dropwise 2 (374 mL, 4.88 mol, 1.5 equiv). The reaction mixture was stirred for 2 h. The solvent was evaporated under reduced pressure and the residue was purified on silica gel to give the title compound 1.0,2-isothiocyano-1,3-dimethoxybenzene (1.06 g, 2.80 mol, 86%) as a white solid . LCMS (ESI cation) m / z: 196 (M+H) + . 1 HNMR (400MHz, CDCl 3 )δ7.16(t, J=8.48Hz, 1H), 6.55(d, J=8.48Hz, 2H), 3.90(s, 6H).

[1269] The compounds listed in the table below were synthesized according to the procedure in Example 1.0 using known starting materials as described.

[1270] Table 1

[1271]

Embodiment 13

[1272] Example 1.3: Preparation of 3-isothiocyano-1-methyl-1H-indole.

[1273]

[1274] (1-Methyl-1H-indol-3-yl)carbamate tert-butyl ester, Example 1.31: To 1-methylindole-3-carboxylic acid (commercially available from Sigma-Aldrich Corp, St. Louis , MO, USA) (10 g, 57.1 mmol) in THF (190 mL) was added sequentially with TEA (7.9 mL, 57.1 mmol) followed by diphenylphosphoryl azide (12.3 mL, 57.1 mmol). The reaction was stirred for 36 h, after which time the reaction was concentrated in vacuo and placed in tert-butanol (54.6 mL). The reaction was further stirred at 90°C over the weekend. After this time, water was added to the reaction and the mixture was extracted with EtOAc and concentrated in vacuo. The residue was purified on silica gel eluting with 0-30% EtOAc in hexanes to give 1.31 (7.1 g, 28.8 mmol, 51%). LCMS-ESI(+)m / z: 247.3(M+H) + .

[1275]

[1276] 1-Methyl-1H-indol-3-amine, Example 1.32: To a stirred solution of 1.31 (7.1 g, 28.8 mmol) in EtOAc (96 mL) w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

Compounds of formula I and formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof, are agonists of the APJ receptor and are useful in the treatment of cardiovascular and other conditions. Compounds of formula I and formula II have the structure: wherein the definitions of the variables are provided herein.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS [0002] This application claims the benefit of US Provisional Application No. 62 / 164,106, filed May 20, 2015, which is incorporated herein by reference in its entirety for all purposes as if fully set forth herein. technical field [0003] The present invention relates to compounds capable of acting as agonists of APJ receptors and compositions comprising compounds that are agonists of APJ receptors. The compounds and compositions are useful for activating APJ receptors and treating a variety of disease conditions. An example of one area in which such compounds can be used is in the treatment of cardiovascular conditions. In particular, the compounds are useful for improving contractility and ejection fraction in subjects with chronic heart failure, and for treating patients with heart failure and reduced ejection fraction and those with heart failure and ejection fraction reserved patients. [0004] Background of the Inventio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/14A61K31/4196A61K31/4439A61P9/00C07D413/04C07D401/04
CPCA61K31/4196A61K31/437A61K31/4439A61K31/444A61K31/497A61K31/501A61K31/506A61K31/513A61K31/695A61K45/06A61P3/04A61P3/10A61P9/04A61P9/12A61P13/12C07B57/00C07B59/002C07B2200/05C07B2200/07C07C311/13C07D211/54C07D213/61C07D213/71C07D213/82C07D239/26C07D239/30C07D239/34C07D241/12C07D241/18C07D241/24C07D249/08C07D295/16C07D401/04C07D401/12C07D401/14C07D405/14C07D413/04C07D413/14C07D417/14C07D471/04C07F7/08A61P9/00
Inventor N.陈X.陈Y.陈A.C.程R.V.康诺尔斯J.戴南P.J.德兰斯菲尔德X.杜Z.付J.A.希思D.B.霍尔恩J.霍泽M.R.卡勒A.Y.哈库D.J.科佩基S-J.赖Z.马L.R.麦吉J.C.梅迪娜J.T.米哈利奇N.尼施穆拉S.H.奥尔森V.帕塔罗彭G.斯瓦米纳思X.王K.杨W-C.叶M.V.德贝内德托R.P.法雷尔S.J.赫德利T.C.朱德F.凯泽
Owner AMGEN INC